UNSPSC 51283513: Nafcillin sodium

This classification denotes an anti-bacterial agent with the molecular formula C21H21N2O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49G3001BCK, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo- but more generally known as nafcillin sodium, which bears US NIH Compound Identifier 8982. European Medicines Agency schedules Nafcillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03375MIG.

UNSPSC 51283513 Nafcillin sodium is a Commodity code that, despite its specific pharmaceutical designation, shows recent state and local procurement activity dominated by broader pharmaceutical and medical supply sourcing rather than nafcillin specifically. State and local governments use this code family to procure generic multi-source pharmaceuticals, over-the-counter products, and emergency medical supplies through competitive bidding and cooperative purchasing vehicles. Issuing bodies span state health and human services agencies, county health departments, cities, and fire rescue divisions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, and the Texas Health and Human Services Commission represent state-level repeat activity; county health departments and municipal fire services (Seminole County, Florida and City of Tampa) demonstrate local engagement in pharmaceutical procurement.

Recent opportunities show geographically distributed activity across Florida, Texas, and Minnesota, with multistate cooperative purchasing extending to Oregon. Representative recent solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries to the county health building; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies to the Fire Department Rescue Division, estimated at $700,000 and sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) seeking generic multi-source pharmaceutical and OTC product manufacturers through authorized wholesalers with contract effectiveness July 1, 2026. The Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) reflects exploratory market research into direct-to-manufacturer prescription programs rather than immediate procurement volume.